AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 196 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2024. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $28,310,607 | +9.8% | 693,066 | -31.4% | 0.01% | 0.0% |
| Q1 2024 | $25,779,487 | +89.9% | 1,010,168 | -32.6% | 0.01% | +75.0% |
| Q4 2023 | $13,573,975 | +33.7% | 1,499,773 | -5.7% | 0.00% | +33.3% |
| Q3 2023 | $10,150,437 | -52.0% | 1,590,874 | -16.5% | 0.00% | -57.1% |
| Q2 2023 | $21,130,586 | +8.5% | 1,905,373 | +50.2% | 0.01% | 0.0% |
| Q1 2023 | $19,481,256 | +95097.7% | 1,268,790 | +37.6% | 0.01% | +16.7% |
| Q4 2022 | $20,464 | -99.8% | 922,104 | +39.7% | 0.01% | +50.0% |
| Q3 2022 | $10,779,000 | +45.4% | 660,039 | +29.4% | 0.00% | +33.3% |
| Q2 2022 | $7,413,000 | +7.7% | 510,271 | +36.9% | 0.00% | +50.0% |
| Q1 2022 | $6,884,000 | +45.3% | 372,752 | +86.9% | 0.00% | +100.0% |
| Q4 2021 | $4,739,000 | +120.4% | 199,387 | +128.4% | 0.00% | 0.0% |
| Q3 2021 | $2,150,000 | – | 87,303 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 926,454 | $25,556,000 | 5.11% |
| EcoR1 Capital, LLC | 2,103,950 | $59,458,000 | 4.39% |
| RTW INVESTMENTS, LP | 3,995,000 | $103,863,000 | 2.92% |
| Cormorant Asset Management, LP | 2,514,547 | $67,804,000 | 2.59% |
| Boxer Capital, LLC | 1,121,327 | $31,689,000 | 1.39% |
| ACUTA CAPITAL PARTNERS, LLC | 117,500 | $3,321,000 | 0.96% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 877,011 | $24,784,000 | 0.72% |
| Pinz Capital Management, LP | 50,000 | $1,413,000 | 0.65% |
| Matrix Capital Management Company, LP | 1,200,000 | $33,912,000 | 0.53% |
| Perceptive Advisors | 1,235,818 | $31,613,000 | 0.51% |